Cardiovascular Core Lab

Cardiovascular Core Lab

Inner Human Body DiagramGlobal Experience

Medpace Cardiovascular Core Lab (MCCL) is a leading comprehensive ECG core laboratory, and an integral piece of the Medpace full-service CRO product offering. MCCL has extensive global experience with trial design, data interpretation and analysis, global study management, and regulatory strategy consultation. Connected to everything else happening globally within the development program, MCCL provides ECG acquisition and analysis services utilizing industry standard devices and systems, allowing ECG results to be interpreted in the context of all the other data Medpace provides within the study as a whole, for faster decision making.

MCCL is the clear choice when you need expert cardiovascular services that are tightly integrated with the rest of the activities within your clinical development program. Medpace has a large team of specialists to provide consulting expertise within the wide range of disciplines you would expect from a global CRO, and a 60,000 sq.ft. Phase I Unit on campus with 84 beds. MCCL is the partner you need to ensure your cardiac safety endpoints are well designed and executed upon within all stages of clinical development.

Consulting Expertise

Phase I/TQT

Phase II/IV

Protocol Design Thorough QT Studies Operations in over 50 Countries
Protocol Review Exposure-QT Response Studies Global Equipment Logistics
Statistical Advisory Cardio-Oncology Localized Training Support
Statistical Study Analysis On-site Phase I Unit 24x7x365 Technical Support
Regulatory Consultation Mortara Surveyor 12-Lead Telemetry Mortara EII 150c ECG Devices
Medical Writing Integrated Project Management ClinTrak Database Integration
Data Management FDA ECG Warehouse Upload Near Real-Time Data Access

Capabilities

  • 12-lead Digital ECGs
  • 12-lead Digital Holter Analysis – 24 or 48 hour continuous monitoring and now up to 7 days monitoring is available for potential arrhythmias, myocardial ischemia, and ST segment analysis
  • Ambulatory Blood Pressure Monitoring (ABPM)
  • Alert ECGs reviewed within 2 hours
  • Non-alert ECGs reviewed within 48 hours
  • Customizable Alert Criteria Notification dependent on Sponsor protocols